Join us next week at #NucleaiAcademy to learn how advanced spatial and AI-driven approaches combined with multiplex imaging (mIF) can accelerate #biomarkerdiscovery for #immunotherapy response. RSVP 👉 https://t.co/WVOV9EDckk

🔬Join us at World CB & CDx 2025 to learn how spatial biomarkers are shaping ADC development. 👉 Book a meeting: https://t.co/GQA4krlkrs #WorldCDx25 #WorldCDx #WorldCDx2025 #CDx #ADC #spatialbiomarkers #aipathology #digitalpathology #biomarkers

The Cathepsin L finding challenges how we align #biomarkers with #ADC MOA. If payload release can occur extracellularly, independent of target engagement, are we still using the right criteria for patient selection and trial design? 👉 https://t.co/5iSHaw4LXp

🔍 Gain insights into #immunotherapy resistance at #NucleaiAcademy with Dr. Ettai Markovits: ✨ Novel metabolic #biomarker signature linked to resistance ✨ AI-powered spatial analysis of #mIF datasets 🔗 Register here: https://t.co/KSXdXPBXA7

What if an ADC’s #bystander effect doesn’t need internalization? A new study shows T-DXd releases payload via cathepsin L in TME—challenging #ADC #biomarker strategies to look beyond target expression. Read more> https://t.co/40AhLFA9Bm #breastcancer #HER2

🎓Nucleai Academy returns this September! Dr. Ettai Markovits shares findings from a study with UQ & Yale revealing a metabolic signature linked to IO resistance—powered by mIF and deep learning. 📅 Register: https://t.co/dkO4iXQN7a #biomarker #Immunotherapy #spatialbiomarkers

Learn how Nucleai's AI-powered spatial proteomics can help qualify ADC and multispecific targets 📥 Download full poster https://t.co/yoSy3y6XTR #spatialbiomarkers #biomarkers #aipathology #digitalpathology #precisionmedicine

Explore how AI spatial proteomics and OD-based quantitative scoring of IHC assays can help you derisk your ADC programs. Book a demo https://t.co/EvcoqE2MHc #DigitalPathology #AIpathology #spatialbiomarkers #PrecisionMedicine

Our Head of Pathology, Dr. Ken Bloom, joined @DDWJournal & @Proscia to discuss how AI-powered spatial proteomics helps de-risk next-gen therapies like multispecifics, IO, and ADCs. 🎥 Watch on demand: https://t.co/PAqJbitxui #biomarkers #precisionmedicine #DigitalPathology

In honor of Cancer #Immunotherapy Month, we're highlighting recent research that explores how AI-powered #spatialbiomarkers can help uncover insights into the TME and support a better understanding of treatment response and resistance.#immune2cancer https://t.co/J74XGfpaZz

Missed our latest #NucleaiAcademy with Dr. Ken Bloom? Watch on demand to explore how OD-based scoring and spatial analysis support ADC development. 📺 Watch the recording: https://t.co/MtPSuG4g5G #biomarkers #precisionmedicine #spatialbiomarkers #aipathology #digitalpathology

📢This coming Monday, join Dr. Ken Bloom as he explores the challenges of patient selection for ADCs—and how OD-based #biomarker scoring and computational pathology can provide deeper insights into target expression and drug activity.🔗 https://t.co/yXk0HksH5c #NucleaiAcademy

One week to go! 🎓 Join Dr. Ken Bloom on June 16 for a live #NucleaiAcademy #webinar exploring how OD-based quantitative #biomarker scoring and spatial analysis can support ADC drug development. 📅 Monday, June 16 | 11:00 AM ET RSVP ➡️ https://t.co/nopXMNIFCh

Closing out an incredible week at #ASCO25! Thank you to everyone who stopped by, shared insights, or joined the conversation. Couldn’t make it to Chicago? We’re offering virtual live demos of our ADC solution suite → https://t.co/S3MsmlBuBY #SpatialBiomarkers #DigitalPathology

Our #ASCO2025 poster is now live! In collaboration with @lunaphoreand Dr. Paolo A. Ascierto, we present new data using mIF + AI-powered spatial analysis to uncover tumor microenvironment features linked to #immunotherapy response. 📄 https://t.co/2pFKlZj6gu #SpatialBiomarkers

Missed our poster session today? In collaboration with @lunaphore and Dr. Paolo A. Ascierto, we presented new data on predictive #SpatialBiomarkers in #melanoma. Visit our booth to learn more! https://t.co/LX0RgCBl7V #ASCO25

It’s showtime! 🎬 We’re all set at ASCO 2025 — stop by Booth IH02 for live demos of our ADC solution suite. #ADCDevelopment #SpatialBiomarkers #AIPathology #DigitalPathology #PrecisionOncology #ASCO25

📢 Our #ASCO25 abstract is now live - developed in collaboration with @lunaphore and Dr. Paolo Ascierto, we present new data on predictive #SpatialBiomarkers in #melanoma. Poster #9524 | June 1 | 9–12 CT 📍 Booth IH02 | Melanoma Session 👉 https://t.co/xu9sSUjBRr

Our ADC Suite of Solutions helps bridge the gap from correlation to causality, delivering clinically meaningful insights from complex data to support biomarker-informed trial design. The suite will be showcased at #ASCO25. Read the announcement → https://t.co/qsC5xPY7dg

We’re Showcasing an ADC Solution Suite For AI Biomarker Scoring Book a demo at ASCO to see how AI spatial proteomics and OD-based IHC scoring can support your ADC development. 📅 Book a demo → https://t.co/fMZMMAASie